- Home
- USPH vs NKTR Comparison
USPH vs NKTR Comparison
Compare USPH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USPH
- NKTR
- Stock Information
- Founded
- USPH 1990
- NKTR 1990
- Country
- USPH United States
- NKTR United States
- Employees
- USPH N/A
- NKTR N/A
- Industry
- USPH Medical/Nursing Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- USPH Health Care
- NKTR Health Care
- Exchange
- USPH Nasdaq
- NKTR Nasdaq
- Market Cap
- USPH 1.1B
- NKTR 1.1B
- IPO Year
- USPH 1992
- NKTR 1994
- Fundamental
- Price
- USPH $75.23
- NKTR $65.87
- Analyst Decision
- USPH Strong Buy
- NKTR Strong Buy
- Analyst Count
- USPH 5
- NKTR 6
- Target Price
- USPH $108.20
- NKTR $106.33
- AVG Volume (30 Days)
- USPH 205.1K
- NKTR 714.7K
- Earning Date
- USPH 11-05-2025
- NKTR 11-06-2025
- Dividend Yield
- USPH 2.43%
- NKTR N/A
- EPS Growth
- USPH 153.49
- NKTR N/A
- EPS
- USPH 2.38
- NKTR N/A
- Revenue
- USPH $750,948,000.00
- NKTR $62,600,000.00
- Revenue This Year
- USPH $18.73
- NKTR N/A
- Revenue Next Year
- USPH $6.13
- NKTR N/A
- P/E Ratio
- USPH $31.11
- NKTR N/A
- Revenue Growth
- USPH 17.51
- NKTR N/A
- 52 Week Low
- USPH $62.77
- NKTR $6.48
- 52 Week High
- USPH $101.20
- NKTR $66.92
- Technical
- Relative Strength Index (RSI)
- USPH 44.47
- NKTR 61.68
- Support Level
- USPH $66.67
- NKTR $53.29
- Resistance Level
- USPH $73.93
- NKTR $61.81
- Average True Range (ATR)
- USPH 3.49
- NKTR 3.89
- MACD
- USPH 0.34
- NKTR 0.43
- Stochastic Oscillator
- USPH 64.95
- NKTR 94.81
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.